WASHINGTON (Reuters) - A combination of two experimental AIDS drugs can help control the deadly virus in people who are infected with highly resistant forms, an international team of researchers reported on Thursday.The two drugs -- called etravirine, or TMC125, and darunavir, or TMC114 -- are both made by Tibotec Pharmaceuticals, Ltd., a division of Johnson & Johnson.